Evidence map›Paper›PMID 31432786›Full record

ArticleIET nanobiotechnology2019

PEG-Citrate dendrimer second generation: is this a good carrier for imaging agents

Pardis Mohammadzadeh, Mehdi Shafiee Ardestani, Sobhan Mortazavi-Derazkola, Ahmad Bitarafan-Rajabi, Seyedeh Masoumeh Ghoreishi

Open access · bronzeAbstract read
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Pardis MohammadzadehDepartment of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mehdi Shafiee ArdestaniDepartment of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Sobhan Mortazavi-DerazkolaPharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Ahmad Bitarafan-RajabiEchocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Seyedeh Masoumeh GhoreishiCancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran. m.ghoreishi@mubabol.ac.ir.
Tehran University of Medical Sciences · IRBabol University of Medical Sciences · IRMazandaran University of Medical Sciences · IRShaheed Rajaei Cardiovascular Medical and Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While cancer is the leading cause of human's deaths worldwide, finding an imaging agent which can detect cancer tumours is needed for cancer diagnosis. In the present study, PEG-citrate dendrimer-G

Indexed as

CitratesCitric AcidDendrimersDiagnostic ImagingDrug CarriersFluorescein-5-isothiocyanateFluorescent DyesHEK293 CellsHumansMCF-7 CellsPolyethylene GlycolsStaining and LabelingCitratesCitric AcidDendrimersDrug CarriersFluorescein-5-isothiocyanateFluorescent DyesPolyethylene Glycols

Identifiers

PMID31432786
PMCPMC8676229
OpenAlexW2924846919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.